BR112018075223A2 - assinaturas de biomarcador de lúpus eritematoso sistêmico e usos das mesmas - Google Patents

assinaturas de biomarcador de lúpus eritematoso sistêmico e usos das mesmas

Info

Publication number
BR112018075223A2
BR112018075223A2 BR112018075223-1A BR112018075223A BR112018075223A2 BR 112018075223 A2 BR112018075223 A2 BR 112018075223A2 BR 112018075223 A BR112018075223 A BR 112018075223A BR 112018075223 A2 BR112018075223 A2 BR 112018075223A2
Authority
BR
Brazil
Prior art keywords
systemic lupus
lupus erythematosus
signatures
biomarker
amount
Prior art date
Application number
BR112018075223-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Borrebaeck Carl
Delfani Payam
Dexlin Mellby Linda
Wingren Christer
Original Assignee
Immunovia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunovia Ab filed Critical Immunovia Ab
Publication of BR112018075223A2 publication Critical patent/BR112018075223A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/104—Lupus erythematosus [SLE]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
BR112018075223-1A 2016-06-07 2017-06-07 assinaturas de biomarcador de lúpus eritematoso sistêmico e usos das mesmas BR112018075223A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1609951.7 2016-06-07
GBGB1609951.7A GB201609951D0 (en) 2016-06-07 2016-06-07 Biomarkers signatures and uses thereof
PCT/EP2017/063855 WO2017211896A1 (en) 2016-06-07 2017-06-07 Biomarker signatures of systemic lupus erythematosus and uses thereof

Publications (1)

Publication Number Publication Date
BR112018075223A2 true BR112018075223A2 (pt) 2019-03-19

Family

ID=56508210

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018075223-1A BR112018075223A2 (pt) 2016-06-07 2017-06-07 assinaturas de biomarcador de lúpus eritematoso sistêmico e usos das mesmas

Country Status (12)

Country Link
US (2) US20200041504A1 (enExample)
EP (1) EP3465209A1 (enExample)
JP (1) JP2019526810A (enExample)
KR (1) KR20190038791A (enExample)
CN (1) CN109690312A (enExample)
AU (1) AU2017277583A1 (enExample)
BR (1) BR112018075223A2 (enExample)
CA (1) CA3026574A1 (enExample)
GB (1) GB201609951D0 (enExample)
MX (1) MX2018015140A (enExample)
RU (1) RU2018142846A (enExample)
WO (1) WO2017211896A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201014837D0 (en) 2010-09-07 2010-10-20 Immunovia Ab Biomarker signatures and uses thereof
WO2020081204A1 (en) * 2018-10-18 2020-04-23 Oklahoma Medical Research Foundation Biomarkers for a systemic lupus erythematosus (sle) disease activity immune index that characterizes disease activity
GB201904472D0 (en) * 2019-03-29 2019-05-15 Immunovia Ab Methods, arrays and uses thereof
CN118948243B (zh) * 2024-07-23 2025-10-17 中国医科大学附属第一医院 基于机器学习对神经精神狼疮进行影像组学诊断的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0039578B1 (en) 1980-05-02 1985-04-10 Edward P. Davis Leg aid device
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5856090A (en) 1994-09-09 1999-01-05 The Scripps Research Institute DNA-methylase linking reaction
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
US20070141627A1 (en) * 2005-10-19 2007-06-21 Behrens Timothy W Systemic Lupus Erythematosus
GB201014837D0 (en) * 2010-09-07 2010-10-20 Immunovia Ab Biomarker signatures and uses thereof
WO2014008426A2 (en) * 2012-07-06 2014-01-09 Ignyta, Inc. Diagnosis of systemic lupus erythematosus
US20160223537A1 (en) * 2013-09-11 2016-08-04 Singapore Health Services Pte Ltd Identification of novel biomarkers of flares of systemic lupus erythematosus
GB201319878D0 (en) * 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof
GB201410226D0 (en) * 2014-06-09 2014-07-23 Immunovia Ab Methods and arrays for use in the same
CA2997838A1 (en) * 2014-10-07 2016-04-14 University Health Network Urinary biomarkers for sle and lupus nephritis

Also Published As

Publication number Publication date
WO2017211896A9 (en) 2019-03-14
RU2018142846A (ru) 2020-07-09
US20200041504A1 (en) 2020-02-06
JP2019526810A (ja) 2019-09-19
EP3465209A1 (en) 2019-04-10
MX2018015140A (es) 2019-08-16
US20230063017A1 (en) 2023-03-02
GB201609951D0 (en) 2016-07-20
AU2017277583A1 (en) 2019-01-03
WO2017211896A1 (en) 2017-12-14
KR20190038791A (ko) 2019-04-09
CN109690312A (zh) 2019-04-26
AU2017277583A9 (en) 2019-08-01
CA3026574A1 (en) 2017-12-14
RU2018142846A3 (enExample) 2020-09-16

Similar Documents

Publication Publication Date Title
BR112018073178A2 (pt) método, matriz e uso dos mesmos
BR112016010510A2 (pt) método, arranjo e uso do mesmo
BR112016019836A2 (pt) método para analisar uma amostra de um sujeito, dispositivo de diagnóstico para utilização no diagnóstico da endometriose, kit, uso de um biomarcador, e, método para aumentar uma resposta de anticorpos em um sujeito
BR112014007214A2 (pt) predição de evento de risco cardiovascular e utilização do mesmo
BR112013003391A2 (pt) biomarcadores de câncer pancreático e usos dos mesmos
BR112014011818A2 (pt) método para realizar ensaios de quantificação
BR112014006432A2 (pt) biomarcadores do câncer de pulmão e seus usos
BR112018072627A2 (pt) realização de medições óticas em uma amostra
BR112014029233A8 (pt) método para diagnosticar se um indivíduo grávido não está em risco, usos de pelo menos um dos biomarcadores sfit-1, endoglina e pigf, dispositivo, kit, método de gestão de um indivíduo, sistema e método para estabelecer um auxílio
WO2017050939A3 (en) Method and array for diagnosing pancreatic cancer in an individual
WO2014186761A3 (en) Methods for determining responsiveness to an anti-cd47 agent
BR112018075223A2 (pt) assinaturas de biomarcador de lúpus eritematoso sistêmico e usos das mesmas
BR112016018044A2 (pt) teste de diagnóstico molecular para prever resposta às drogas antiangiogênicas e prognóstico de câncer
BR112014031182A2 (pt) método para testar uma formação, sistema para testar a pressão de uma formação e meio de armazenamento legível por computador
BR112017023726A2 (pt) detecção de fatores de virulência microbiana na cavidade oral
GB201014837D0 (en) Biomarker signatures and uses thereof
MX2019008911A (es) Metodos, matrices y usos de estos.
BR112017008218A2 (pt) métodos e composições para diagnóstico e prognóstico de lesão renal e insuficiência renal
BR112016019740A2 (pt) monitoramento do estado de inflamação
BR112018015034A2 (pt) sistema de marcação de massa carregada
BR112017011026A2 (pt) métodos analíticos e arranjos para uso nos mesmos
BR112015025255A2 (pt) métodos e arranjos para uso no mesmo
BRPI0722361B8 (pt) métodos para avaliar a concentração de um fármaco imunossupressor em uma amostra de sangue humano, composição de reagente de extração e kit de teste
BR112017006315A2 (pt) agente terapêutico, uso de um agente terapêutico, métodos in vitro para determinar se um sujeito com melanoma tem um risco maior de desenvolver metástase, de determinação de um regime de tratamento para um sujeito que sofre de melanoma, de tratamento de um sujeito que sofre de melanoma, ensaio in vitro para predizer o risco aumentado de metástase e kits
WO2015189591A3 (en) Method and arrays for use in diagnosing early breast cancer

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2673 DE 29-03-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.